EurekaMag
+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Vaccination with leishmanial antigen and CpG oligodeoxynucleotides confers long-term protection against Leishmania major infection


Vaccination with leishmanial antigen and CpG oligodeoxynucleotides confers long-term protection against Leishmania major infection



FASEB Journal 16(4): A307



ISSN/ISBN: 0892-6638

Vaccination of susceptible Balb/c mice with a plasmid DNA encoding a specific leishmanial antigen induced more durable immunity and effective control of infection compared to vaccination with leishmanial protein plus IL-12 protein. Mechanisms to explain these findings include the fact plasmid DNA vaccines contain immunostimulatory CpG motifs that have been shown to induce more durable Th1 responses in vivo when compared to IL-12 protein. Thus it was hypothesized that CpG ODN might induce more durable immunity and protection than IL-12 when used as a vaccine adjuvant with leishmanial protein. In these studies, using two different models of Leishmania major infection, susceptible Balb/c and resistant C57B1/6 mice were primed and boosted two weeks later with L. major protein with or without CpG ODN. Mice were then challenged either 2 or 12 weeks post-boost with L. major. In both models, mice vaccinated with leishmanial protein plus CpG ODN controlled infection when challenged 12 weeks post-boost. Current studies are evaluating the immune correlates of protection, focusing on the qualitative and quantitative aspects of Th1 responses and the role of CD8+ T cells.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 036024548

Download citation: RISBibTeXText

Related references

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection. Journal of Experimental Medicine 195(12): 1565-1573, 2002

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice. Infection and Immunity 70(6): 2828-2836, 2002

Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models. Plos Neglected Tropical Diseases 11(5): E0005644, 2017

Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection. Fems Immunology and Medical Microbiology 42(2): 241-248, 2004

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model. Molecular Immunology 67(2 Pt B): 501-511, 2015

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine 21(3-4): 247-257, 2002

Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route. Molecular Pharmaceutics 9(1): 59-70, 2012

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. Vaccine 27(1): 99-106, 2008

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice. Plos Neglected Tropical Diseases 14(1): E0007939, 2020

Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice. Memorias do Instituto Oswaldo Cruz 94(1): 71-76, 1999

Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes and Infection 10(10-11): 1133-1141, 2008

A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major. Infection and Immunity 82(7): 2736-2745, 2014

A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection. Parasitology International 50(2): 81-91, 2001

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. Journal of Experimental Medicine 186(7): 1137-1147, 1997

DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection. Vaccine 25(22): 4502-4509, 2007